| TRATTNIG, S, C SCOTTI, D LAURENT, V JURAS, S HACKER, B COLE, Libor PAŠA, R LEHOVEC, P SZOMOLANYI, E RAITHEL, F SAXER, J PRAESTGAARD, Gamba F LA, JL JIMENEZ, DS RAMOS, R ROUBENOFF and M SCHIEKER. ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS. 2021. Available from: https://dx.doi.org/10.1136/annrheumdis-2021-eular.447. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1836200,
author = {Trattnig, S and Scotti, C and Laurent, D and Juras, V and Hacker, S and Cole, B and Paša, Libor and Lehovec, R and Szomolanyi, P and Raithel, E and Saxer, F and Praestgaard, J and La, Gamba F and Jimenez, JL and Ramos, DS and Roubenoff, R and Schieker, M},
doi = {http://dx.doi.org/10.1136/annrheumdis-2021-eular.447},
language = {eng},
title = {ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS},
year = {2021}
}
TY - CONF
ID - 1836200
AU - Trattnig, S - Scotti, C - Laurent, D - Juras, V - Hacker, S - Cole, B - Paša, Libor - Lehovec, R - Szomolanyi, P - Raithel, E - Saxer, F - Praestgaard, J - La, Gamba F - Jimenez, JL - Ramos, DS - Roubenoff, R - Schieker, M
PY - 2021
TI - ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS
ER -
TRATTNIG, S, C SCOTTI, D LAURENT, V JURAS, S HACKER, B COLE, Libor PAŠA, R LEHOVEC, P SZOMOLANYI, E RAITHEL, F SAXER, J PRAESTGAARD, Gamba F LA, JL JIMENEZ, DS RAMOS, R ROUBENOFF and M SCHIEKER. \textit{ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS}. 2021. Available from: https://dx.doi.org/10.1136/annrheumdis-2021-eular.447.
|
